FDA Greenlights Expanded Use Of Boston Scientific’s Pulse Field Ablation System
A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.